TH-17:: a giant step from TH1 and TH2

被引:124
作者
Wynn, TA [1 ]
机构
[1] NIAID, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni1105-1069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4+ T cells have been classically separated into two dominant effector populations: T helper types 1 and 2. Two new studies suggest that T cells producing interleukin 17 constitute a previously unknown lineage of CD4+ T cells.
引用
收藏
页码:1069 / 1070
页数:3
相关论文
共 12 条
[1]   Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].
Aggarwal, S ;
Ghilardi, N ;
Xie, MH ;
de Sauvage, FJ ;
Gurney, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914
[2]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[3]   Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J].
Harrington, LE ;
Hatton, RD ;
Mangan, PR ;
Turner, H ;
Murphy, TL ;
Murphy, KM ;
Weaver, CT .
NATURE IMMUNOLOGY, 2005, 6 (11) :1123-1132
[4]   Interleukin-17 family members and inflammation [J].
Kolls, JK ;
Lindén, A .
IMMUNITY, 2004, 21 (04) :467-476
[5]   IL-23 drives a pathogenic T cell population that induces autoimmune inflammation [J].
Langrish, CL ;
Chen, Y ;
Blumenschein, WM ;
Mattson, J ;
Basham, B ;
Sedgwick, JD ;
McClanahan, T ;
Kastelein, RA ;
Cua, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (02) :233-240
[6]   Divergent pro- and Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation [J].
Murphy, CA ;
Langrish, CL ;
Chen, Y ;
Blumenschein, C ;
McClanahan, T ;
Kastelein, RA ;
Sedgwick, JD ;
Cua, DJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1951-1957
[7]   Antigen-specific T cell Sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses [J].
Nakae, S ;
Komiyama, Y ;
Nambu, A ;
Sudo, K ;
Iwase, M ;
Homma, I ;
Sekikawa, K ;
Asano, M ;
Iwakura, Y .
IMMUNITY, 2002, 17 (03) :375-387
[8]   IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist [J].
Nakae, S ;
Saijo, S ;
Horai, R ;
Sudo, K ;
Mori, S ;
Iwakura, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :5986-5990
[9]   Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 [J].
Oppmann, B ;
Lesley, R ;
Blom, B ;
Timans, JC ;
Xu, YM ;
Hunte, B ;
Vega, F ;
Yu, N ;
Wang, J ;
Singh, K ;
Zonin, F ;
Vaisberg, E ;
Churakova, T ;
Liu, MR ;
Gorman, D ;
Wagner, J ;
Zurawski, S ;
Liu, YJ ;
Abrams, JS ;
Moore, KW ;
Rennick, D ;
de Waal-Malefyt, R ;
Hannum, C ;
Bazan, JF ;
Kastelein, RA .
IMMUNITY, 2000, 13 (05) :715-725
[10]   A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R [J].
Parham, C ;
Chirica, M ;
Timans, J ;
Vaisberg, E ;
Travis, M ;
Cheung, J ;
Pflanz, S ;
Zhang, R ;
Singh, KP ;
Vega, F ;
To, W ;
Wagner, J ;
O'Farrell, AM ;
McClanahan, T ;
Zurawski, S ;
Hannum, C ;
Gorman, D ;
Rennick, DM ;
Kastelein, RA ;
Malefyt, RD ;
Moore, KW .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5699-5708